Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that it enclosed details of loss of share certificates/request for issue of duplicate share certificate reported by/received from shareholders of the Company, received from Registrar and Transfer Agent, Link Intime India on March 11, 2023.
The above information is a part of company’s filings submitted to BSE.